ColoWatch, Inc. /MD/ — SEC Form D Filing

ColoWatch, Inc. /MD/ filed an SEC Form D on October 8, 2026, reporting $975K raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
October 8, 2026
Amount reported
$975K
Round stage
Seed stage, as a $975,000 debt offering typically represents early-stage runway extension or bridge financing for product development and initial clinical validation.
Industry
Other Health Care
Website
https://www.colowatch.com

What the company does

Securities: Debt. Revenue: $1 - $1,000,000. Exemption: Rule 506(b). Incorporated: MARYLAND

Problem

Healthcare providers lack continuous, non-invasive monitoring solutions to detect early signs of colorectal complications or disease recurrence in patients post-procedure.

Solution

ColoWatch, Inc. /MD/ develops a specialized monitoring platform and device-based system designed to track colorectal health indicators and alert clinicians to early warning signs.

Why now

The rapid shift toward remote patient monitoring and value-based care models is driving healthcare systems to adopt proactive, home-based surveillance technologies.

Source: SEC EDGAR Form D filing